Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

Masuda, Takeshi, Wang, Xin, Maeda, Manami, Canver, Matthew C., Sher, Falak, Funnell, Alister P. W., Fisher, Chris, Suciu, Maria +12 more·2016·Science

DOI 10.1126/science.aad3312

Cited by (373)

Items 101–200 of 373

Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies
Boya Liu, Christian Brendel, Divya S. Vinjamur, Yu Zhou, Chad Everett Harris, Meaghan K. McGuinness, John P. Manis, Daniel E. Bauer, Haiming Xu, David A. Williams · 2022 · Molecular Therapy
Embryonic erythropoiesis and hemoglobin switching require transcriptional repressor ETO2 to modulate chromatin organization
Xiang Guo, Jennifer L. Plank-Bazinet, Ivan V. Krivega, Ryan Dale, Ann Dean · 2020 · Nucleic Acids Research
The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders
Christopher B. Chambers, Jeffrey Gross, Katherine L. Pratt, Xiang Guo, Colleen Byrnes, Y. Terry Lee, Donald Lavelle, Ann Dean, Jeffery Lynn Miller, Andrew C. Wilber · 2020 · Molecular Therapy — Methods & Clinical Development
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
Tolulope O. Rosanwo, Daniel E. Bauer · 2021 · Molecular Therapy
CRISPR-Cas technology a new era in genomic engineering
Ali Parsaeimehr, Rosemary I. Ebirim, Gulnihal Ozbay · 2022 · Biotechnology Reports
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Kiriaki Paschoudi, Evangelia Yannaki, Nikoletta Psatha · 2023 · International Journal of Molecular Sciences
Tough decoy targeting of predominant let-7 miRNA species in adult human hematopoietic cells
Jaira Ferreira de Vasconcellos, Colleen Byrnes, Y. Terry Lee, Joshua M. Allwardt, Megha Kaushal, Antoinette Rabel, Jeffery Lynn Miller · 2017 · Journal of Translational Medicine
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Gabriel Salinas Cisneros, Swee Lay Thein · 2021 · HemaSphere
Beta‐thalassemia and the advent of new interventions beyond transfusion and iron chelation
Waseem Chauhan, Shoaib Shoaib, Rafat Fatma, Zeeba Zaka‐ur‐Rab, Mohammad Afzal · 2022 · British Journal of Clinical Pharmacology
Zbtb7a induction in alveolar macrophages is implicated in anti-HLA–mediated lung allograft rejection
Deepak K. Nayak, Fangyu Zhou, Min Xu, Jing Huang, Moriya Tsuji, Jinsheng Yu, Ramsey R. Hachem, Andrew E. Gelman, Ross Macrae Bremner, Michael A. Smith et al. · 2017 · Science Translational Medicine
Robust CRISPR/Cas9 Genome Editing of the HUDEP-2 Erythroid Precursor Line Using Plasmids and Single-Stranded Oligonucleotide Donors
Gemma Moir-Meyer, Pak Leng Cheong, Aude-Anaïs Olijnik, Jill M. Brown, Samantha J.L. Knight, Andrew John King, Ryo Kurita, Yukio Nakamura, Richard J. Gibbons, Douglas R. Higgs et al. · 2018 · Methods and Protocols
Cellular Basis of Embryonic Hematopoiesis and Its Implications in Prenatal Erythropoiesis
Toshiyuki Yamane · 2020 · International Journal of Molecular Sciences
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient
Lilian Varricchio, Antanas Planutis, Deepa G. Manwani, Julie Jaffray, William Beau Mitchell, Anna Ritá Migliaccio, James J. Bieker · 2019 · Haematologica
An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells
Masato Miyata, Nynke Gillemans, Dorit Hockman, Jeroen Demmers, Jan‐Fang Cheng, Jun Hou, Matti Salminen, Christopher A. Fisher, Stephen Taylor, Richard J. Gibbons et al. · 2020 · Blood
Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets
Priya Hariharan, Anita HARISH Nadkarni · 2021 · Blood Reviews
The BTB transcription factors ZBTB11 and ZFP131 maintain pluripotency by repressing pro-differentiation genes
Görkem Garipler, Congyi Lu, Alexis Morrissey, Lorena Sofía López-Zepeda, Yingzhen Pei, Simon E. Vidal, Ana Paula Zen Petisco Fiore, Begüm Aydın, Matthias Stadtfeld, Uwe Ohler et al. · 2022 · Cell Reports
NuRD complex recruitment to Thpok mediates CD4 + T cell lineage differentiation
Yayi Gao, Mónica Zamisch, Melanie S. Vacchio, Laura B. Chopp, Thomas Ciucci, Elliott L. Paine, Gaelyn C. Lyons, Jia Nie, Qi Xiao, Ekaterina Zvezdova et al. · 2022 · Science Immunology
Fetal Hemoglobin Regulation in Beta-Thalassemia
Henry Y. Lu, Stuart H. Orkin, Vijay G. Sankaran · 2023 · Hematology/Oncology Clinics of North America
Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
Constantinos C. Loucari, Petros Patsali, Thamar B. van Dijk, Coralea Stephanou, Panayiota L. Papasavva, Maria Zanti, Ryo Kurita, Yukio Nakamura, Soteroulla Christou, Maria Sitarou et al. · 2018 · Human Gene Therapy Methods
Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review
Alexandra O. Sokolova, Anton Mararenko, Alexander Rozin, Alida I. Podrumar, Vladimir K. Gotlieb · 2017 · Hematology/Oncology and Stem Cell Therapy
Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression
Aoi Wakabayashi, Maryanne Kihiu, Malini Sharma, A. Josephine Thrasher, Megan S. Saari, Mathieu Quesnel-Vallières, Osheiza Y. Abdulmalik, Scott A. Peslak, Eugene Khandros, Cheryl A. Keller et al. · 2022 · Blood Advances
Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives
Weilin Zhou, Jinrong Yang, Yalan Zhang, Xiaoyi Hu, Wei Wang · 2022 · MedComm
The future of sickle cell disease therapeutics rests in genomics
Ambroise Wonkam · 2023 · Disease Models & Mechanisms
Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
Letizia Fontana, Zoe Alahouzou, Annarita Miccio, Panagiotis Antoniou · 2023 · Genes
Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia
Silvia Fluhr, Christopher Felix Krombholz, Angelina Meier, Thomas Epting, Oliver Mücke, Christoph Plass, Charlotte Marie Niemeyer, Christian Flotho · 2017 · Epigenetics
Mutant KLF1 in Adult Anemic Nan Mice Leads to Profound Transcriptome Changes and Disordered Erythropoiesis
Danitza Nébor, Joel H. Graber, Steven L. Ciciotte, Raymond F. Robledo, Julien Papoin, Emily Hartman, Kevin Robert Gillinder, Andrew Charles Perkins, James J. Bieker, Lionel Blanc et al. · 2018 · Scientific Reports
Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases
Yaoyao Lu, Cedric Happi Mbakam, Bo Song, Eli Bendavid, Jacques P. Tremblay · 2022 · Frontiers in Genome Editing
Variants of ZBTB7A (LRF) and its β-globin gene cluster binding motifs in sickle cell anemia
Shaikho, Elmutaz M., Habara, Alawi H., Alsultan, Abdulrahman, Al-Rubaish, A.M., Al-Muhanna, Fahad, Naserullah, Z., Alsuliman, A., Qutub, Hatem O., Patra, P.K., Sebastiani, Paola et al. · 2016 · Blood Cells, Molecules, and Diseases
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
James B. Papizan, Shaina N. Porter, Akshay Sharma, Shondra M. Pruett‐Miller · 2020 · Journal of Biomedical Research
3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression
Pamela Himadewi, Xue Qing David Wang, Fan Feng, Haley Gore, Yu-Shuai Liu, Lei Yu, R. Kurita, Yukio Nakamura, G. Pfeifer, Jie Liu et al. · 2021 · bioRxiv
Establishment and characterization of immortalized erythroid progenitor cell lines derived from a common cell source
Ryo Kurita, Koji Funato, TAKAAKI K. ABE, Yoshihisa Watanabe, Masayuki Shiba, Kenji Tadokoro, Yukio Nakamura, Tadashi Nagai, Masahiro Satake · 2018 · Experimental Hematology
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
Vasiliki Chondrou, Eleana F. Stavrou, Georgios S. Markopoulos, Alexandra Kouraklis‐Symeonidis, Vassilis E. Fotopoulos, Argiris S. Symeonidis, Efthymia Vlachaki, Panagiota Chalkia, George P. Patrinos, Adamantia Papachatzopoulou et al. · 2018 · Human Genomics
HRI depletion cooperates with pharmacologic inducers to elevate fetal hemoglobin and reduce sickle cell formation
Scott A. Peslak, Eugene Khandros, Peng Huang, Xianjiang Lan, Carly Lay A. Geronimo, Jeremy D. Grevet, Osheiza Y. Abdulmalik, Zhe Zhang, Belinda M. Giardine, Cheryl A. Keller et al. · 2020 · Blood Advances
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Hidde A. Zittersteijn, Cornelis L. Harteveld, Stefanie Klaver-Flores, Arjan C. Lankester, Rob C. Hoeben, Frank J. T. Staal, Manuel A.F.V. Gonçalves · 2021 · Frontiers in Genome Editing
Transcriptional silencing of fetal hemoglobin expression by NonO
Xinyu Li, Mengxia Chen, Biru Liu, Peifen Lu, Xiang Lv, Xiang Zhao, Shuaiying Cui, Peipei Xu, Yukio Nakamura, Ryo Kurita et al. · 2021 · Nucleic Acids Research
Abnormal regulation of microRNAs and related genes in pediatric β‐thalassemia
Haiwei Wang, Meihuan Chen, Shiyi Xu, Yali Pan, Yanhong Zhang, Hailong Huang, Liangpu Xu · 2021 · Journal of Clinical Laboratory Analysis
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
Nikoletta Psatha, Kiriaki Paschoudi, Αναστασία Παπαδοπούλου, Evangelia Yannaki · 2022 · Genes
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment
Gibran Ali, Muhammad Akram Tariq, Kamran Shahid, Fridoon Jawad Ahmad, Javed Akram · 2020 · Gene Therapy
Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells
Panayiota L. Papasavva, Nikoletta Y. Papaioannou, Petros Patsali, Ryo Kurita, Yukio Nakamura, Maria Sitarou, Soteroulla Christou, Marina Kleanthous, Carsten Werner Lederer · 2021 · International Journal of Molecular Sciences
The BTB-domain transcription factor ZBTB2 recruits chromatin remodelers and a histone chaperone during the exit from pluripotency
Daniel Olivieri, Sujani Paramanathan, Anaïs F. Bardet, Daniel Heß, Sébastien A. Smallwood, Ulrich Elling, Joerg Betschinger · 2021 · Journal of Biological Chemistry
A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
Ge Zheng, Maolu Yin, Stuti Mehta, I-Te Chu, Stacy Wang, Alia Alshaye, Kirstin Drainville, Altantsetseg Buyanbat, Frédérique Bienfait, Karin Tenglin et al. · 2024 · Science
GATA zinc finger domain‐containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with β‐thalassaemia through impaired formation of methyl‐binding domain protein 2 (MBD2)‐containing nucleosome remodelling and deacetylation (NuRD) complex
Yunhao Liang, Xinhua Zhang, Yongqiong Liu, Liren Wang, Yuhua Ye, Xuemei Tan, Jiajie Pu, Qianqian Zhang, Xiuqin Bao, Xiaofeng Wei et al. · 2021 · British Journal of Haematology
Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics
Deborah E. Daniels, Daniel C. J. Ferguson, Rebecca E. Griffiths, Kongtana Trakarnsanga, Nicola M. Cogan, Katherine A. MacInnes, Kathryn E. Mordue, Tatiana Andrienko, Ivan Ferrer Vicens, Daniel Ramos Jiménez et al. · 2021 · Molecular Therapy — Methods & Clinical Development
Exploring epigenetic and microRNA approaches for γ-globin gene regulation
Athena Starlard‐Davenport, Ashley Fitzgerald, Betty S. Pace · 2021 · Experimental Biology and Medicine
SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II
Richard King, Zesen Lin, Ginette Balbin-Cuesta, Greggory Myers, Ann D. Friedman, Guojing Zhu, Beth M. McGee, Thomas L. Saunders, Ryo Kurita, Yukio Nakamura et al. · 2021 · Science Advances
PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin
Reem Elagooz, Anita R. Dhara, Rose M. Gott, Sarah E. Adams, Rachael A. White, Arnab Ghosh, Shinjini Ganguly, Yuncheng Man, Amma Twumwa Owusu-Ansah, Omar Y. Mian et al. · 2022 · Blood Advances
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells
Giulia Pavani, Joshua G. Klein, Catriana C. Nations, Jonathan Sussman, Kai Tan, Hyun Hyung An, Osheiza Y. Abdulmalik, Christopher S. Thom, Peter A. Gearhart, Camryn M. Willett et al. · 2024 · Blood Advances
Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape modulation
Guoyou Liu, Juhyun Kim, Nicole H. Nguyen, Lecong Zhou, Ann Dean · 2024 · Blood
Erythropoiesis in the mammalian embryo
James Palis · 2024 · Experimental Hematology
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
Varun Katta, Kiera O’Keefe, Yichao Li, Thiyagaraj Mayuranathan, Cícera Regina Lazzarotto, Rachael K. Wood, Rachel M. Levine, Alicia Powers, Kalin D. Mayberry, Garret Manquen et al. · 2024 · Molecular Therapy
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease
Michael D. Diamantidis, Georgia Ikonomou, Ioanna Argyrakouli, Despoina Pantelidou, Sophia Delicou · 2024 · International Journal of Molecular Sciences
CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases
Justin S. Antony, A.K.M. Ashiqul Haque, Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Markus Mezger, Michael Kormann · 2018 · Advances in Cell and Gene Therapy
Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells
Abhirup Bagchi, Aneesha Nath, Vasanth Thamodaran, Smitha Ijee, Dhavapriya Palani, Vignesh Rajendiran, Vigneshwaran Venkatesan, Phaneendra Venkateswara Rao Datari, Aswin Anand Pai, Nancy B.J. Arthur et al. · 2021 · Cells
Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
Vigneshwaran Venkatesan, Abisha Crystal Christopher, Manuel Rhiel, Manoj Kumar K. Azhagiri, Prathibha Babu, Kaivalya Walavalkar, Bharath Saravanan, Geoffroy Andrieux, Sumathi Rangaraj, Saranya Srinivasan et al. · 2023 · Molecular Therapy — Nucleic Acids
CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia
Abdulfatah M. Alayoubi, Zakaria Yahya Khawaji, Mohammed A. Mohammed, François Mercier · 2023 · Annals of Hematology
Recent advances in globin research using genome‐wide association studies and gene editing
Stuart H. Orkin · 2016 · Annals of the New York Academy of Sciences
Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis
Cuong Quang Le, Greggory Myers, Alawi H. Habara, Natee Jearawiriyapaisarn, George J. Murphy, David H.K. Chui, Martin H. Steinberg, James Douglas Engel, Shuaiying Cui · 2019 · Blood
Small molecule therapeutics to treat the β-globinopathies
Lei Yu, Greggory Myers, James Douglas Engel · 2020 · Current Opinion in Hematology
Induction of therapeutic levels of HbF in genome‐edited primary β039‐thalassaemia haematopoietic stem and progenitor cells
Maura Mingoia, Cristian Antonio Caria, Lin Ye, Isadora Asunis, Maria Franca Marongiu, Laura Manunza, Maria Carla Sollaino, Jiaming Wang, Annalisa Cabriolu, Ryo Kurita et al. · 2020 · British Journal of Haematology
What Is Known about Theragnostic Strategies in Colorectal Cancer
Alessandro Parisi, Giampiero Porzio, Fanny Pulcini, Katia Cannita, Corrado Ficorella, Vincenzo Mattei, Simona Delle Monache · 2021 · Biomedicines
Targeting fetal hemoglobin expression to treat β hemoglobinopathies
Martin H. Steinberg · 2022 · Expert Opinion on Therapeutic Targets
Molecular basis of polycomb group protein-mediated fetal hemoglobin repression
Kunhua Qin, Xianjiang Lan, Peng Huang, Megan S. Saari, Eugene Khandros, Cheryl A. Keller, Belinda M. Giardine, Osheiza Y. Abdulmalik, Junwei Shi, Ross C. Hardison et al. · 2023 · Blood
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
Lushen Li, Pankaj Kumar Mandal · 2024 · Frontiers in Hematology
TREATING HEMOGLOBINOPATHIES USING GENE CORRECTION APPROACHES: PROMISES AND CHALLENGES
Renee N. Cottle, Ciaran M. Lee, Gang Bao · 2016 · Human Genetics
Sustained fetal hemoglobin induction in vivo is achieved by BCL11A interference and coexpressed truncated erythropoietin receptor
Naoya Uchida, Francesca Ferrara, Claire M. Drysdale, Morgan Yapundich, Jackson Gamer, Tina Nassehi, Julia DiNicola, Yoshitaka Shibata, Matthew M. Wielgosz, Yoon‐Sang Kim et al. · 2021 · Science Translational Medicine
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Marja W. Wessels, Marjon H. Cnossen, Thamar B. van Dijk, Nynke Gillemans, K. L. Juliëtte Schmidt, Kirsten van Lom, Divya S. Vinjamur, Steven M. Coyne, Ryo Kurita, Yukio Nakamura et al. · 2021 · Blood Advances
Novel therapies in β‐thalassaemia
Laura Grech, Karen Borg, Joseph Borg · 2021 · British Journal of Clinical Pharmacology
Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts
Steven Heshusius, Laura Grech, Nynke Gillemans, Rutger W. W. Brouwer, Alexander T. den Dekker, Wilfred F. J. van IJcken, Benjamin Nota, Alex E. Felice, Thamar B. van Dijk, Marieke v. Lindern et al. · 2022 · Scientific Reports
The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy
Stuart H. Orkin · 2025 · New England Journal of Medicine
Targeted Protein Degradation as a Promising Tool for Epigenetic Upregulation of Fetal Hemoglobin
Thijs C. J. Verheul, Van Tuan Trinh, Olalla Vázquez, Sjaak Philipsen · 2020 · ChemMedChem
Structural basis for transcription factor ZBTB7A recognition of DNA and effects of ZBTB7A somatic mutations that occur in human acute myeloid leukemia
Ren Ren, John R. Horton, Qin Chen, Jie Yang, Bin Liu, Yun Huang, Robert Blumenthal, Xing Zhang, Xiaodong Cheng · 2023 · Journal of Biological Chemistry
Distinct subsets of multi-lymphoid progenitors support ontogeny-related changes in human lymphopoiesis
Seydou Keita, Samuel Diop, Shalva Lekiashvili, Emna Chabaane, Elisabeth Nelson, Marion Strullu, Chloé Arfeuille, Fabien Guimiot, Thomas Domet, Sophie Duchez et al. · 2023 · Cell Reports
Epigenetic interplay at the β-globin locus
Wei Shern Lee, Bradley McColl, Jovana Maksimovic, Jim Vadolas · 2017 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Revisiting fetal hemoglobin inducers in beta-hemoglobinopathies: a review of natural products, conventional and combinatorial therapies
Mandrita Mukherjee, Motiur Rahaman, Suman Kumar Ray, Praphulla Chandra Shukla, Tuphan Kanti Dolai, Nishant Chakravorty · 2021 · Molecular Biology Reports
Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
D. E. Bauer, C. Brendel, C. Fitzhugh · 2017 · Blood Cells, Molecules & Diseases
Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
Claudio Mussolino, John Strouboulis · 2021 · Frontiers in Genome Editing
Gene Therapy for Hemoglobinopathies
Maria Rosa Lidonnici, Samantha Scaramuzza, Giuliana Ferrari · 2023 · Human Gene Therapy
Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data
Angela E. Rivers, Ramasamy Jagadeeswaran, Donald Lavelle · 2018 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Current and future gene therapies for hemoglobinopathies
Christian Brendel, David A. Williams · 2020 · Current Opinion in Hematology
Heterozygous variants in ZBTB7A cause a neurodevelopmental disorder associated with symptomatic overgrowth of pharyngeal lymphoid tissue, macrocephaly, and elevated fetal hemoglobin
Charlotte von der Lippe, Kristian Tveten, Trine Prescott, Øystein L. Holla, Øyvind L. Busk, Katherine Burke, Francis H. Sansbury, Júlia Baptista, Andrew E. Fry, Derek Lim et al. · 2021 · American Journal of Medical Genetics Part A
Effective therapies for sickle cell disease: are we there yet?
Merlin Crossley, Georgios E. Christakopoulos, Mitchell J. Weiss · 2022 · Trends in Genetics
Removal of promoter CpG methylation by epigenome editing reverses HBG silencing
Henry William Bell, Ruopeng Feng, Manan Shah, Yu Yao, James Douglas, Phillip A. Doerfler, Thiyagaraj Mayuranathan, Michael F O'Dea, Yichao Li, Yong‐Dong Wang et al. · 2025 · Nature Communications
Pharmacologic induction of PGC ‐1α stimulates fetal haemoglobin gene expression
Yanan Sun, Alawi H. Habara, Cuong Quang Le, Nicole Nguyen, Raymon Chen, George J. Murphy, David H.K. Chui, Martin H. Steinberg, Shuaiying Cui · 2022 · British Journal of Haematology
Clinical Manifestations of Sickle Cell Disease Across the Lifespan
Lydia H. Pecker, Jane Alison Little · 2017 · Springer eBooks
Construction and Analysis of a Long Non-Coding RNA (lncRNA)-Associated ceRNA Network in β-Thalassemia and Hereditary Persistence of Fetal Hemoglobin
Wenguang Jia, Siyuan Jia, Ping Chen, Yunyan He · 2019 · Medical Science Monitor
C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies
Xing Zhang, Fangfang Xia, Xiaotian Zhang, Robert Blumenthal, Xiaodong Cheng · 2023 · Journal of Molecular Biology
Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease
Shruti Bhatt, Donovan Alexander Argueta, Kalpna Gupta, Suman Kundu · 2023 · Antioxidants and Redox Signaling
Gene therapy and gene editing strategies in inherited blood disorders
Xuemei Song, JinLei Liu, Tangcong Chen, Tingfeng Zheng, Xiaolong Wang, Xiang Guo · 2024 · Journal of genetics and genomics/Journal of Genetics and Genomics
Transcriptional Repressor BCL11A in Erythroid Cells
Ge Zheng, Stuart H. Orkin · 2024 · Advances in experimental medicine and biology
The Nucleosome Remodeling and Deacetylase Complex in Development and Disease
Jeannine M. Basta, Michael I. Rauchman · 2017 · Elsevier eBooks
ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex
Rosita Russo, Veronica Russo, Francesco Cecere, Mariangela Valletta, Maria Teresa Gentile, Luca Colucci-D’Amato, Claudia Angelini, Andrea Riccio, Paolo V. Pedone, Angela Chambery et al. · 2020 · International Journal of Biological Macromolecules
Heterogeneity of fetal hemoglobin production in adult red blood cells
Eugene Khandros, Gerd A. Blobel · 2021 · Current Opinion in Hematology
Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF
Vinzon Ibañez, Kestis Vaitkus, Xu Zhang, Ramasamy Jagadeeswaran, Angela E. Rivers, Yogen Saunthararajah, Robert E. Molokie, Donald Lavelle · 2023 · Blood Advances
HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts
Jaira Ferreira de Vasconcellos, Y. Terry Lee, Colleen Byrnes, Laxminath Tumburu, Antoinette Rabel, Jeffery Lynn Miller · 2016 · PLoS ONE
De novo ZBTB7A variant in a patient with macrocephaly, intellectual disability, and sleep apnea: implications for the phenotypic development in 19p13.3 microdeletions
Akira Ohishi, Yohei Masunaga, Shigeo Iijima, Kaori Yamoto, Fumiko Kato, Maki Fukami, Hirotomo Saitsu, Tsutomu Ogata · 2019 · Journal of Human Genetics
Expression of the adult ADHD-associated gene ADGRL3 is dysregulated by risk variants and environmental risk factors
Rhiannon Victoria McNeill, Viola Stella Palladino, Nathalie Brunkhorst-Kanaan, Oliver Grimm, Andreas Reif, Sarah Kittel‐Schneider · 2020 · The World Journal of Biological Psychiatry
Hemoglobinopathies and Thalassemias
Scott A. Peslak, Farzana A. Sayani · 2022 · Elsevier eBooks
PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease
Yanan Sun, Hajar Benmhammed, Salam Al Abdullatif, Alawi H. Habara, Eric Fu, Jordan Brady, Christopher Williams, Adrian Ilinski, Anusha Sharma, Kiana Mahdaviani et al. · 2024 · Science Advances
A genome-wide screen identifies genes required for erythroid differentiation
Greggory Myers, Ann D. Friedman, Lei Yu, Narges Pourmandi, Claire Kerpet, Masaki A. Ito, Rilie Saba, Vi T. Tang, Ayse Bilge Ozel, Ingrid L. Bergin et al. · 2025 · Nature Communications
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects
Louis H. Junker, Yaqin Li, Xingguo Zhu, Sivanagireddy Koti, Ryan E. Cerbone, Clifford L. Hendrick, José Sangerman, Susan P. Perrine, Betty S. Pace · 2021 · Blood Cells Molecules and Diseases